StockData

Exicure, Inc. (XCUR) stock

XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 20, 2026Score 4/30
$0.90−0.08 (-8.15%)

Close on Nov 20, 2026Market cap $5.89MP/E –Yield –

Exicure net income

Net income is the profit left for shareholders after every expense, interest and tax.

Exicure's net income for the twelve months ending Sep 30, 2026 was -$5.21M. For fiscal 2025 it was -$4.95M. The highest annual figure on record is -$2.58M in fiscal 2022.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$4.95M–
FY2024Dec 31, 2024-$9.70M–
FY2023Dec 31, 2023-$16.91M–
FY2022Dec 31, 2022-$2.58M–
FY2021Dec 31, 2021-$64.10M–
FY2020Dec 31, 2020-$24.67M–
FY2019Dec 31, 2019-$26.30M–
FY2018Dec 31, 2018-$22.41M–
FY2017Dec 31, 2017-$11.01M–
FY2016Dec 31, 2016-$16.94M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$642.00K–
Q2 FY2026Jun 30, 2026-$1.12M–
Q1 FY2026Mar 31, 2026-$1.83M-160.7%
Q4 FY2025Dec 31, 2025-$2.90M–
Q3 FY2025Sep 30, 2025-$2.44M–
Q2 FY2025Jun 30, 2025-$2.62M–
Q1 FY2025Mar 31, 2025$3.01M–
Q4 FY2024Dec 31, 2024-$7.18M–
Q3 FY2024Sep 30, 2024-$1.09M–
Q2 FY2024Jun 30, 2024-$600.00K–
Q1 FY2024Mar 31, 2024-$829.00K–
Q4 FY2023Dec 31, 2023-$1.49M-108.1%
Q3 FY2023Sep 30, 2023-$5.26M–
Q2 FY2023Jun 30, 2023-$5.76M–
Q1 FY2023Mar 31, 2023-$4.41M–
Q4 FY2022Dec 31, 2022$18.40M–
Q3 FY2022Sep 30, 2022-$5.16M–
Q2 FY2022Jun 30, 2022-$7.47M–
Q1 FY2022Mar 31, 2022-$8.35M–
Q4 FY2021Dec 31, 2021-$13.83M–
Q3 FY2021Sep 30, 2021-$23.53M–
Q2 FY2021Jun 30, 2021-$14.27M–
Q1 FY2021Mar 31, 2021-$12.48M-1185.0%
Q4 FY2020Dec 31, 2020-$12.69M–
Q3 FY2020Sep 30, 2020-$8.82M–
Q2 FY2020Jun 30, 2020-$4.31M–
Q1 FY2020Mar 31, 2020$1.15M–
Q4 FY2019Dec 31, 2019-$9.98M–
Q3 FY2019Sep 30, 2019-$5.82M–
Q2 FY2019Jun 30, 2019-$5.22M–
Q1 FY2019Mar 31, 2019-$5.29M–
Q4 FY2018Dec 31, 2018-$4.76M–
Q3 FY2018Sep 30, 2018-$5.32M–
Q2 FY2018Jun 30, 2018-$6.83M–
Q1 FY2018Mar 31, 2018-$5.51M–
Q4 FY2017Dec 31, 2017-$3.44M–
Q2 FY2017Aug 31, 2017-$12.28K–
Q4 FY2016Dec 31, 2016-$5.64M–

More Exicure figures

See a number that looks wrong?